| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 267.08 | 86 |
| GSM780708 | Untreated after 4 days (C2_1) | 191.562 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 161.095 | 81 |
| GSM780719 | Untreated after 4 days (C1_2) | 250.32 | 86 |
| GSM780720 | Untreated after 4 days (C2_2) | 209.167 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 203.757 | 84 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 193.513 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 251.42 | 86 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 244.304 | 86 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 179.965 | 82 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 272.886 | 87 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 273.038 | 87 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 230.579 | 85 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 180.643 | 82 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 277.677 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 280.303 | 87 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 211.11 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 244.911 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 327.466 | 88 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 253.773 | 86 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 212.956 | 84 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 315.122 | 88 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 276.815 | 87 |